In line with these findings, NFAs were reported to suppress the growth of aggressive breast cancer cells by inhibiting NF-κB transcriptional activity, thereby suppressing downstream NF-κB target gene expression (Woodcock et al., 2018). Here, NFKB1 is linked to breast carcinoma.